Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2026-02-25 Transaction in Own Shar…
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a formal notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the transaction date, the total value, and the resulting change in the company's treasury share holdings. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-02-25 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification about the sale of treasury shares by the company, including specific details on the number of shares sold, percentage of share capital, and transaction value. It references compliance with EU regulation on market abuse (art. 17 of Regulation (EU) No 596/2014), which governs insider information and market transparency. The content is focused on a transaction involving the company's own shares, not a financial report or announcement of a report. The document length is short (724 characters), and it is a direct report of a share transaction by the company itself. Therefore, it fits the category of Transaction in Own Shares (POS).
2026-02-24 Polish
Reminder for Annual Investor Meeting on 27 February 2026
Regulatory Filings
2026-02-23 Polish
Notification for sales revenues for January 2026
Regulatory Filings Classification · 95% confidence The document is a short notification (556 characters) issued by Sopharma AD regarding monthly sales performance for January 2026. It is not a full financial report, but rather a brief regulatory update on sales figures as required by the Law on Public Offering of Securities. Since it provides specific financial performance data (sales decrease) rather than just announcing the availability of a report, it fits best as a general regulatory filing.
2026-02-20 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It explicitly details the number of shares sold, the percentage of share capital, the total value, and the resulting balance of treasury shares. This falls under the category of a company reporting on the transaction of its own shares (share buyback or sale).
2026-02-13 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It explicitly details the number of shares sold, the transaction date, the total value, and the resulting balance of treasury shares. This falls under the category of a company reporting on the transaction of its own shares (share buyback or sale).
2026-02-12 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.